Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
about
Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection.Development of an In Vitro Assay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria.Differentially Culturable Tubercule Bacilli are Generated During Non-pulmonary Tuberculosis Infection.Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016.Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.Sub-minimum inhibitory concentration of rifampin: a potential risk factor for resuscitation of Mycobacterium tuberculosis.A Method to Evaluate Persistent Mycobacterium tuberculosis In Vitro and in the Cornell Mouse Model of Tuberculosis.Characterising resuscitation promoting factor fluorescent-fusions in mycobacteria.Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest.Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.
P2860
Q33810290-EAF44025-AD0C-4527-86BA-CE76A1D292B4Q38880052-25828962-97C4-46E0-9FCE-3022E2974902Q39509772-2F9E674C-C1BC-4393-B43E-53D4CC99C0FDQ40062861-07106A84-E5AF-43EC-B5BD-4D6EF9B20E99Q40463792-2A86A047-8A82-4FB3-896A-7FFFC8FC5815Q40622419-2360913B-6146-4845-808F-2C1AEE6DF8E4Q45351074-341433DF-DDD1-4159-9F6A-8A9AD8CF1BCAQ50097333-3FB29FD3-3536-4B13-A525-688F700D4DFFQ54236819-01BA9C09-D369-4703-90C0-A20F7F336FA0Q54259397-E789EA2E-3430-45EE-B123-73765F79EA4BQ55517885-CD79B21D-E7A9-4D99-B3FC-1E3043B7BF5B
P2860
Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@ast
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@en
type
label
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@ast
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@en
prefLabel
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@ast
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@en
P2093
P2860
P50
P356
P1476
Phenotypically Adapted Mycobac ...... e Tolerant to First-Line Drugs
@en
P2093
Abdullaat S Kadyrov
Asel A Sarybaeva
Benjamin D O'Connor
Caroline Williams
Gerrit Woltmann
Hemu Patel
Obolbek Turapov
P2860
P304
P356
10.1128/AAC.01380-15
P407
P577
2016-03-25T00:00:00Z